| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/19/2004 | WO2004069277A1 Stable dispersion of solid particles comprising a water-insoluble pyrazine compound |
| 08/19/2004 | WO2004069242A1 Anthelmintic composition |
| 08/19/2004 | WO2004069231A1 Transdermal therapeutic system with improved adhesion to the skin |
| 08/19/2004 | WO2004069211A2 Affinity proteins for controlled application of cosmetic substances |
| 08/19/2004 | WO2004069208A2 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | WO2004069204A2 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | WO2004069201A2 Compounds useful in coating stents to prevent and treat stenosis and restenosis |
| 08/19/2004 | WO2004069193A2 Methods and compositions for inhibiting cholesterol uptake |
| 08/19/2004 | WO2004069187A2 Drug formulation and delivery using crystalline methylated cyclodextrins |
| 08/19/2004 | WO2004069179A2 Improved thickened beverages for dysphagia |
| 08/19/2004 | WO2004069176A2 Polymer conjugates of mutated neublastin |
| 08/19/2004 | WO2004069171A2 Novel compounds for the treatment of sickle cell disease |
| 08/19/2004 | WO2004069134A2 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 08/19/2004 | WO2004069032A2 Viscous swallow medium and method of use for esophageal function testing |
| 08/19/2004 | WO2004068971A1 Chitosan foodstuff |
| 08/19/2004 | WO2004068931A2 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 08/19/2004 | WO2004054356A3 Transgenic animals produced using oral administration of a genetic agent coupled to a transporting agent |
| 08/19/2004 | WO2004047839A8 High concentration formulations of opioids and opioid derivatives |
| 08/19/2004 | WO2004047729A3 Composition for the prevention and treatment of inflammation of the ear |
| 08/19/2004 | WO2004045540A3 Method for continuous, automated blending of solutions from acids and bases |
| 08/19/2004 | WO2004026120A3 Methods for diagnosing and treating tumors and suppressing cd promoters |
| 08/19/2004 | WO2004010957B1 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 08/19/2004 | WO2004006756A3 THERAPIES FOR RENAL FAILURE USING INTERFERON-β |
| 08/19/2004 | WO2003092585A3 Controlled release compositions of estradiol metabolites |
| 08/19/2004 | WO2003087821A3 Method for cleaving and deglycosylating antibodies to promote ligand binding |
| 08/19/2004 | WO2003077834A3 Central airway administration for systemic delivery of therapeutics |
| 08/19/2004 | WO2003034999A3 Medication and method for remediating existing scars through transdermal topical delivery of calcium channel blockers |
| 08/19/2004 | WO2003032912A8 Treatment of cns disorders using cns target modulators |
| 08/19/2004 | WO2003001876A8 T1r hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 08/19/2004 | WO2002089778A3 Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine |
| 08/19/2004 | US20040162580 Sutures and coatings made from therapeutic absorbable glass |
| 08/19/2004 | US20040162412 Stabilized protein preparation and process for its preparation |
| 08/19/2004 | US20040162388 Activated polyethylene glycol esters |
| 08/19/2004 | US20040162351 Making a fused GABA analog prodrug having a cleavable promoiety covalently bound to the therapeutic fused GABA analog;placing prodrug in a sustained release oral dosage form; introducing dosage form into the intestinal lumen of a patient by having the patient swallow the dosage form; releasing, cleaving |
| 08/19/2004 | US20040162344 Effective ingredient and basic agent; foam suppression |
| 08/19/2004 | US20040162330 Stable high-concentration injection containing pyrazolone derivative |
| 08/19/2004 | US20040162301 Minoxidil-containing liquid composition |
| 08/19/2004 | US20040162275 Multivalently interactive molecular assembly, capturing agent, drug carrier, calcium chelating agent, and drug enhancer |
| 08/19/2004 | US20040162272 Chemical enhancer and method |
| 08/19/2004 | US20040162261 Double chain compound having an amino group and a carboxyl group in the hydrophilic part; forms a stable bilayer membrane vesicle in water, and a water-soluble drug can be enclosed in the internal phase of the vesicle at high efficiency |
| 08/19/2004 | US20040162259 Administering oligonucleotide targeted to human ICAM-1 mRNA for therapy |
| 08/19/2004 | US20040162251 Pharmaceutical composition containing decoy and method of using the same |
| 08/19/2004 | US20040162239 For therapy of diseases associated with aberrant vascularization |
| 08/19/2004 | US20040161776 Mixture comprising multimeric prostate specific membrane antigen (PSMA) for use as tools in diagnosis and treatment of cell proliferative disorders |
| 08/19/2004 | US20040161463 Supplying, condensation,forming nucleic acids binding polymers |
| 08/19/2004 | US20040161458 Hard gelatin capsule containing mixture of surfactants |
| 08/19/2004 | US20040161457 Method of administering a compound to multi-drug resistant cells |
| 08/19/2004 | US20040161455 Method for treating multi-drug resistant tumors |
| 08/19/2004 | US20040161443 Vehicle |
| 08/19/2004 | US20040161441 Containing permethrin, imidacloprid and n-methylpyrrolidone; killing ticks and fleas; skin friendly, low toxicity; storage stability |
| 08/19/2004 | US20040161434 Nonaqueous liquid; acceptable taste; diluting in aqueous diluent for oral administration |
| 08/19/2004 | US20040161430 Dye-azide compounds for dual phototherapy |
| 08/19/2004 | US20040161428 Such as transferrin-doxorubicin conjugate linked by gluteraldehyde; inexpensive, effective |
| 08/19/2004 | US20040161407 Medicinal compositions |
| 08/19/2004 | US20040161405 Guanidinium transport reagents and conjugates |
| 08/19/2004 | US20040161403 Applicable for water insoluble, hydrophilic and charge bearing bioactive agents; controlled release |
| 08/19/2004 | US20040161385 Delivery of beta-blockers through an inhalation route |
| 08/19/2004 | DE20220917U1 Zusammensetzungen zur Verhinderung des Missbrauchs von Opioiden Compositions to prevent the misuse of opioids |
| 08/19/2004 | DE19945578B4 Kosmetische und/oder pharmazeutische Zubereitungen und deren Verwendung Cosmetic and / or pharmaceutical preparations and the use thereof |
| 08/19/2004 | DE19734544B4 Schellackhaltiges kosmetisches Produkt und Verfahren zu dessen Herstellung Shellac-containing cosmetic product and process for its preparation |
| 08/19/2004 | DE10305531A1 New tubulysin compound conjugates with polymers or biomolecules, having reduced toxicity compared with parent tubulysin, especially useful for treating tumor diseases |
| 08/19/2004 | DE10305098A1 New effector conjugates of epithilones useful to treat e.g. diseases associated with proliferative processes, neurodegenerative diseases, multiple sclerosis, Alzheimer's disease and rheumatoid arthritis |
| 08/19/2004 | CA2814767A1 Combination therapy for treating protein deficiency disorders |
| 08/19/2004 | CA2694872A1 Improved thickened beverages for dysphagia |
| 08/19/2004 | CA2515125A1 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515107A1 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515100A1 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | CA2515081A1 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 08/19/2004 | CA2514952A1 Chitosan foodstuff |
| 08/19/2004 | CA2514841A1 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | CA2514510A1 Polymer conjugates of mutated neublastin |
| 08/19/2004 | CA2509459A1 Affinity proteins for controlled application of cosmetic substances |
| 08/18/2004 | EP1447343A2 Injection moulded water-soluble container |
| 08/18/2004 | EP1447099A2 Antineoplastic polyethylene conjugates of cytostatic compounds and pharmaceuticals comprising same |
| 08/18/2004 | EP1447098A2 Therapeutic inhibitor of vascular smooth muscle cells |
| 08/18/2004 | EP1447097A1 Percutaneous absorption type medicinal preparation |
| 08/18/2004 | EP1447086A1 An aqueous metal bicarbonate solution and method of use |
| 08/18/2004 | EP1447084A1 Freeze-dried pharmaceutical preparation |
| 08/18/2004 | EP1447082A1 Non-;gelatinous capsule film compositions and capsules using the same |
| 08/18/2004 | EP1447081A1 Sugar-modified liposome and products comprising the liposome |
| 08/18/2004 | EP1447079A1 Vesicles with chimeric receptors to induce a targeted T-cell response in vivo |
| 08/18/2004 | EP1446504A2 Emulsion compositions |
| 08/18/2004 | EP1446501A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 08/18/2004 | EP1446453A1 Synthetic matrix for controlled cell ingrowth and tissue regeneration and endometriosis |
| 08/18/2004 | EP1446438A2 Branched polymers and their conjugates |
| 08/18/2004 | EP1446423A2 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders |
| 08/18/2004 | EP1446418A2 Integrin targeting compounds |
| 08/18/2004 | EP1446167A2 Treating canker sores with patches to speed healing and relieve pain |
| 08/18/2004 | EP1446163A2 Multidrug multiligand conjugates for targeted drug delivery |
| 08/18/2004 | EP1446161A2 Medicinal combination of biguanine (metformin) and arginine |
| 08/18/2004 | EP1446160A1 Aspirin-containing transdermal pharmaceutical composition for the treatment of calcification |
| 08/18/2004 | EP1446140A2 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 08/18/2004 | EP1446138A2 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 08/18/2004 | EP1446136A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 08/18/2004 | EP1446126A1 Coated particulate cefuroxime axetil compositions |
| 08/18/2004 | EP1446119A2 Compositions comprising ipatropium and xylometazoline for treatment of the common cold |
| 08/18/2004 | EP1446118A1 Oral dosage form of a sulfonamide prodrug such as parecoxib |
| 08/18/2004 | EP1446109A1 Methods and compositions for use of (s)-bisoprolol |
| 08/18/2004 | EP1446107A1 Process for the preparation of tablets comprising s-adenosylmethionine |
| 08/18/2004 | EP1446106A2 Optimal polymer mixtures for gastric retentive tablets |